Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAL vs ALA for Actinic Keratosis
NCT02647151Phase 4Unknown
- Sponsor
- Fundación Instituto Valenciano de Oncología (IVO)
- Start
- Dec 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of 5-aminolevulinic acid in actinic keratosis (AK), sponsored by Fundación Instituto Valenciano de Oncología (IVO). Status: unknown.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02647151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647151.